pattern photo
YEARS
Mankind Pharma's consolidated net profit has increased by 29 percent to Rs 658.88 crore in the July-September quarter of the current financial year. While giving this information, the company said that it has earned this profit due to increase in sales volume. The company's net profit in the same quarter of the last financial year was Rs 511.18 crore.
New Delhi. Mankind Pharma's consolidated net profit has increased by 29 percent to Rs 658.88 crore in the July-September quarter of the current financial year. Giving this information, the company said that it has earned this profit due to increase in sales volume. The company's net profit in the same quarter of the last financial year was Rs 511.18 crore. Mankind Pharma, the country's fourth largest pharmaceutical company, said its operating income increased by 13.6 percent to Rs 3,076.51 crore in the September quarter, from Rs 2,708.10 crore in the same quarter of the last financial year.
Rajeev Juneja, Vice Chairman and Managing Director, MannKind Pharma, said, “The company had a stable revenue growth of 13.6 per cent and a strong EBITDA margin of 27.7 per cent. “This was possible due to volume improvement, continued outperformance in weak segments.” The company's total expenses increased by 9.8 percent to Rs 2,339.19 crore in the September quarter. Mankind Pharma's total income (including other income) increased by 15.09 percent to Rs 3,185.94 crore in the September quarter. The company's domestic income increased by 11 per cent to Rs 2,796 crore in the September quarter, while export income increased by 57 per cent to Rs 281 crore.
Disclaimer: Prabhasakshi has not edited this news. This news has been published from PTI-language feed.
other news
